L impacte ambiental dels aliments a Dilluns començo ccma.cat - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ccma.cat Daily Mail and Mail on Sunday newspapers.
Linus Health Raises $55M in Series B Funding finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.
Therapeutic platform for brain disorders uses targeted multi-channel neuromodulation to deliver personalized treatment protocols to patients anywhere. Neuroelectrics, a pioneer in brain stimulation
Five-Minute Digital Clock Test May Speed Alzheimer s Diagnosis medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
MedRhythms, in collaboration with Boston University, is launching a clinical trial of its pipeline asset MR-005 in Parkinson’s disease (PD).
In addition, the company is expanding its pipeline into aging with the development of its Aging Scientific Advisory Board (SAB). This follows MedRhythms’ announcement of the advancement of its pipeline into PD and multiple sclerosis (MS) in 2020 with the initiation of clinical trials and the development of MS and PD SABs.
MedRhythms, headquartered in Portland, Me, is a digital therapeutics company that builds direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury.